Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...
An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...
Researchers at the University of Nottingham have developed a new genetic test that can diagnose brain tumours in as little as 2 hours. The test, called ROBIN, uses PromethION nanopore sequencing to ...
Prenatal imaging identified situs inversus totalis, and whole exome sequencing found DNAH11 variants. The case highlights how ...
Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease Women age 20-79 years diagnosed ...
Genetic testing for ATTR can detect transthyretin mutations and offer crucial information about risk, monitoring, and treatment, if needed. Transthyretin amyloidosis (ATTR) is a genetic condition that ...
Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results